Literature DB >> 8727137

Cerebral hyperemia after arteriovenous malformation resection is related to "breakthrough" complications but not to feeding artery pressure. The Columbia University Arteriovenous Malformation Study Project.

W L Young1, A Kader, E Ornstein, K Z Baker, N Ostapkovich, J Pile-Spellman, P Fogarty-Mack, B M Stein.   

Abstract

To study the pathophysiology of idiopathic postoperative brain swelling or hemorrhage after arteriovenous malformation resection, termed normal perfusion pressure breakthrough (NPPB), we performed cerebral blood flow (CBF) studies during 152 operations in 143 patients, using the xenon-133 intravenous injection method. In the first part of the study, CBF was intraoperatively measured (isoflurane/N2O anesthesia) during relative hypocapnia in 95 patients before and after resection. The NPPB group had a greater increase (P < 0.0001) in mean +/- standard deviation global CBF (28 +/- 6 to 47 +/- 16 ml/100 g/min, n = 5) than did the non-NPPB group (25 +/- 7 to 29 +/- 10 ml/100 g/min, n = 90); both arteriovenous malformation groups showed greater increase (P < 0.05) than did controls undergoing craniotomy for tumor (23 +/- 6 to 23 +/- 6 ml/100 g/min, n = 22). Ipsilateral and contralateral CBF changes were similar. In a second cohort of patients with arteriovenous malformations, CBF was measured at relative normocapnia and it increased (P < 0.002) from pre- to postresection (40 +/- 13 to 49 +/- 15 ml/100 g/min, n = 57). There were no NPPB patients in this latter cohort. The feeding mean arterial pressure was measured intraoperatively before resection or at the last embolization before surgery (n = 64). The feeding mean arterial pressure (44 +/- 16 mm Hg) was 56% of the systemic arterial pressure (78 +/- 12 mm Hg, P < 0.0001) and was not related to changes in CBF from pre- to postresection. There was an association between increases in global CBF from pre- to postresection and NPPB-type complications, but there was no relationship of these CBF changes to preoperative regional arterial hypotension. These data do not support a uniquely hemodynamic mechanism that explains cerebral hyperemia as a consequence of repressurization in hypotensive vascular beds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727137     DOI: 10.1097/00006123-199606000-00005

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

Review 1.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

Review 2.  Normal perfusion pressure breakthrough theory: a reappraisal after 35 years.

Authors:  Leonardo Rangel-Castilla; Robert F Spetzler; Peter Nakaji
Journal:  Neurosurg Rev       Date:  2014-12-09       Impact factor: 3.042

3.  Revisiting normal perfusion pressure breakthrough in light of hemorrhage-induced vasospasm.

Authors:  Matthew D Alexander; E Sander Connolly; Philip M Meyers
Journal:  World J Radiol       Date:  2010-06-28

4.  Toward normal perfusion after radiosurgery: perfusion MR Imaging with independent component analysis of brain arteriovenous malformations.

Authors:  Wan-Yuo Guo; Yu-Te Wu; Hsiu-Mei Wu; Wen-Yuh Chung; Yi-Hsuan Kao; Tzu-Chen Yeh; Cheng-Ying Shiau; D Hung-Chi Pan; Yue-Cune Chang; Jen-Chuen Hsieh
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

Review 5.  Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns.

Authors:  A R Deibler; J M Pollock; R A Kraft; H Tan; J H Burdette; J A Maldjian
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 6.  Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations.

Authors:  H Kim; D A Marchuk; L Pawlikowska; Y Chen; H Su; G Y Yang; W L Young
Journal:  Acta Neurochir Suppl       Date:  2008

7.  Multimodality Treatment of Brain Arteriovenous Malformations with One-Staged Hybrid Operation: Clinical Characteristics and Long-Term Prognosis.

Authors:  Yuanfeng Jiang; Chaofan Zeng; Yiqun Zhang; Xiaobo Xu; Hancheng Qiu; Weijian Jiang
Journal:  Dis Markers       Date:  2022-02-27       Impact factor: 3.434

Review 8.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

9.  Ascertaining the Value of Noninvasive Measures Obtained Using Color Duplex Ultrasound and Central Aortic Pressure Monitoring During the Management of Cerebral Arteriovenous Malformation Resection: Protocol for a Prospective, Case Control Pilot Study.

Authors:  Kathryn J Busch; Hosen Kiat
Journal:  JMIR Res Protoc       Date:  2017-08-31

10.  Neuroprotective effect of indomethacin in normal perfusion pressure breakthrough phenomenon.

Authors:  Manuel Revuelta; Alvaro Zamarrón; Jose Fortes; Gregorio Rodríguez-Boto; Raquel Gutiérrez-González
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.